Allosteric Interactions of Gaba- and Glycine-Gated Chloride Channels from Rat Brain

Total Page:16

File Type:pdf, Size:1020Kb

Allosteric Interactions of Gaba- and Glycine-Gated Chloride Channels from Rat Brain TITLE ALLOSTERIC INTERACTIONS OF GABA- AND GLYCINE-GATED CHLORIDE CHANNELS FROM RAT BRAIN A thesis submitted for the Degree of Doctor of Philosophy, University of London Richard John Prince, BSc August 1992 Department of Pharmacology, School of Pharmacy, University of London, 29-39, Brunswick Square, London WC1N 1AX 1 ProQuest Number: U539242 All rights reserved INFORMATION TO ALL USERS The quality of this reproduction is dependent upon the quality of the copy submitted. In the unlikely event that the author did not send a com plete manuscript and there are missing pages, these will be noted. Also, if material had to be removed, a note will indicate the deletion. uest ProQuest U539242 Published by ProQuest LLC(2017). Copyright of the Dissertation is held by the Author. All rights reserved. This work is protected against unauthorized copying under Title 17, United States C ode Microform Edition © ProQuest LLC. ProQuest LLC. 789 East Eisenhower Parkway P.O. Box 1346 Ann Arbor, Ml 48106- 1346 ABSTRACT The allosteric interactions of the GABA a receptor were investigated through the actions of drugs on [H]-flunitrazepam binding. The effects of varying incubation temperature revealed that pentobarbitone is more efficacious a potentiator at low temperatures than at high. In contrast, the general anaesthetics propofol and alphaxalone did not show a variation in efficacy with temperature. These results argue against a membrane site of action for propofol and alphaxalone. Differences in the dependence of potentiation upon anions were also noted. All three drugs gave increased potentiation with increasing concentrations of anions which can permeate the GAB A a receptor. However, whilst the potency of propofol increased with chloride concentration, its efficacy did not Pentobarbitone showed an increase in both potency and efficacy but whilst alphaxalone’s efficacy increased, its potency did not. These results indicate different sites and modes of interaction for propofol, alphaxalone and pentobarbitone. Interactions of the steroid epipregnanolone with the receptor were also characterised. It antagonised competitively the potentiation produced by its isomers pregnanolone and allopregnanolone whilst having little direct effect upon flunitrazepam binding or on potentiation by pentobarbitone and GABA. Epipregnanolone also antagonised the potentiating effect of alphaxalone but the mode of inhibition was different to that seen against pregnanolone, indicating more than one class of binding site for neurosteroids at the GABA a receptor. [3H]-flunitrazepam binding to GABA a receptors immunopurified according to a subunit content was also examined. No potentiation by alphaxalone or pentobarbitone was seen but differences in flunitrazepam affinity and EC50 for potentiation by GABA were noted. In an electrophysiological study, the interaction of steroids with the strychnine-sensitive glycine receptor was examined. Certain corticosteroids were shown to be potent enhancers of the actions of glycine and strychnine at this receptor, but steroids which are active on the GABA a receptor showed no effects. 2 TABLE OF CONTENTS ABSTRACT 2 TABLE OF CONTENTS 3 LIST OF FIGURES 7 LIST OF TABLES 9 CHAPTER 1. GENERAL INTRODUCTION 11 GABA a receptor pharmacology 12 Strychnine sensitive glycine receptor pharmacology 13 Molecular biology of ligand-gated chloride channels 14 Aims and objectives 17 CHAPTER 2. METHODS 20 Electrophysiological studies 21 [3H]-strychnine binding 21 GABA a binding studies 25 Data analysis 30 CHAPTER 3. STEROID ANTAGONISTS AT THE GABA a RECEPTOR 32 5P-pregnan-3p-ol-20-one, a specific antagonist 33 at the steroid site of the GABA a receptor-complex Methods 36 Results 37 Discussion 39 3 Differential antagonism by 3p-hydroxy steroids 43 of alphaxalone and pregnanolone potentiation suggest more than one class of binding site for steroids at GABAa receptors. Methods 47 Results 49 Discussion 57 CHAPTER 4. PROPOFOL POTENTIATES THE BINDING OF 61 [3H]-FLUNITRAZEPAM t o THE GABA a RECEPTOR COMPLEX Methods 65 Results 67 Discussion 76 CHAPTER 5. TEMPERATURE AND ANION DEPENDENCE OF 80 ALLOSTERIC INTERACTIONS AT THE y-AMINOBUTYRIC ACID RECEPTOR Methods 84 Results 86 Discussion 99 4 Chapter 6. STEROID INTERACTIONS AT THE STRYCHNINE 104 SENSITIVE GLYCINE RECEPTOR Electrophysiological studies 105 Methods 107 Results 108 Discussion 117 Binding studies 120 Results 120 Discussion 122 CHAPTER 7. CHARACTERISATION OF IMMUNOPURIFIED 124 GABA a RECEPTORS Allosteric interactions of immunopurified receptors 125 Methods 129 Results 132 Discussion 139 [3H]-muscimol/benzodiazepine binding to 143 immunopurified receptors Methods 143 Results 143 Discussion 146 5 CHAPTER 8. GENERAL DISCUSSION 148 Sites of action 149 Nature of the binding sites 152 One site or many? 154 Endogenous ligands 156 Future perspectives 157 ACKNOWLEDGEMENTS 163 APPENDIX I: STEROID STRUCTURES 164 REFERENCES 165 6 List of Figures and Tables Figure 1.1 Membrane disposition of direct-ligand gated ion channels 2.1 Grease gap apparatus used in electrophysiological experiments 3.1 Competitive antagonism of pregnanolone potentiation of [3H]-flunitrazepam binding by epipregnanolone 3.2 Effect of epipregnanolone on pentobarbitone potentiation of [3H]-flunitrazepam binding 3.3 Concentration effect curves for the potentiation of [3H]-flunitrazepam binding by pregnanolone and epipregnanolone 3.4 Competitive antagonism of allopregnanolone’s potentiation of [3H]-flunitrazepam binding by epipregnanolone 3.5 Effect of epipregnanolone upon alphaxalone potentiation of [3H]-flunitrazepam binding 3.6 Effect of alphaxalone on enhancement of [3H]-flunitrazepam binding by pregnanolone 4.1 Interaction of propofol and NaCl in enhancing [3H]-flunitrazepam binding 4.2 Effect of NaCl on propofol’s EC50 4.3 Propofol enhances the affinity of [3H]-flunitrazepam Figure Page 4.4 Effect of propofol on alphaxalone and pentobarbitone interactions 73 5.1 Van’t Hoff plots for [3H]-flunitrazepam binding ± various drugs 92 5.2 Effect of alphaxalone, propofol and pentobarbitone in the presence 95 and absence of 200mM NaCl on [3H]-flunitrazepam binding 5.3 Effect of NaCl on [3H]-flunitrazepam binding ± various drugs 97 5.4 Potentiation of [3H]-flunitrazepam binding by propofol, 98 pentobarbitone and alphaxalone at various [NaCl]. 6.1 Potentiation of glycine responses by DHC 112 6.2 Interaction of strychnine and DHC on responses to glycine 114 6.3 Fade of glycine responses induced by hydrocortisone 116 6.4 Action of DHC on [3H]-strychnine binding 121 7.1 Potentiation by GABA of [3H]-flunitrazepam binding to membranes 134 and immunopurified receptors 7.2 Effect of pentobarbitone and alphaxalone on [3H]-flunitrazepam 135 binding to membranes and immunopurified receptors 7.3 Chloride dependency of [3H]-flunitrazepam 136 binding to membranes and immunopurified receptors 8.1 Model for the interaction of lipids with ligand-gated ion channels 159 8.2 Major pathways for pregnanolone production in the brain 161 8 Table Page 3.1 Parameters for the potentiation of [3H]-flunitrazepam binding 51 by pregnanolone and allopregnanolone under various conditions 3.2 Effect of 36-OH steroids on the potentiation of [3H]-flunitrazepam 52 binding by alphaxalone and 56-alphaxalone 4.1 Effect of various salts on the EC50 of propofol for the potentiation 74 of [3H]-flunitrazepam binding 4.2 Effect of propofol upon concentration effect parameters for the 75 potentiation of [3H]-flunitrazepam by alphaxalone and pentobarbitone 5.1 Thermodynamic parameters for [3H]-flunitrazepam binding in the 89 presence of propofol, alphaxalone and pentobarbitone 5.2 EC50s of propofol, alphaxalone and pentobarbitone at 4 and 37°C 90 for the potentiation of [3H]-flunitrazepam binding 5.3 EC50s of propofol, alphaxalone and pentobarbitone in the presence 91 of various salts 6.1 Log shifts of the dose response curve to glycine 111 7.1 EC50s for GABA, pentobarbitone and alphaxalone enhancement of 137 [3H]-flunitrazepam binding to native and immunopurified receptors 7.2 Affinity of [3H]-flunitrazepam in native and immunopurified 138 receptors at 4 and 37°C ± lOOpM GABA 9 Table Page 7.3 Kd values for muscimol, R015 1788 and flunitrazepam in 144 immunopurified receptors 7.4 Benzodiazepine/muscimol binding ratios in immunopurified receptors 145 10 CHAPTER 1 General Introduction 11 Chapter 1: General Introduction GENERAL INTRODUCTION Fast synaptic inhibition in the central nervous system is largely mediated by chloride ion channels gated by the inhibitory amino acids glycine and GABA (Y-aminobutyric acid). In the higher areas of the CNS, GABA is the dominant inhibitory transmitter whilst in the spinal cord this function is fulfilled by glycine. Up-regulation of these systems results in an increase in synaptic inhibition which manifests itself in sedation, anaesthesia and muscle relaxation, whilst a decrease in inhibitory function causes hyperexcitability resulting in convulsions, and epileptiform activity. Alterations in inhibitory function are both implicated in disease and exploited in therapeutic strategy (Martin, 1987; Lloyd et al, 1984; Faingold and Browning, 1987; Buckle et al> 1989). Many of the best known and most widely-prescribed hypnotic drugs act at the GAB Aa receptor. Pharmacology of theGABA a receptor In addition to gating by the neurotransmitter GABA, the GABA a receptor is modulated by a wide range of drugs acting at distinct loci (for reviews see Tallman and Gallager, 1985; Stephenson, 1988; Schwartz, 1988). These substances allosterically modulate both the GABA binding
Recommended publications
  • Effect of Isopregnanolone on Rapid Tolerance to the Anxiolytic Effect of Ethanol Influência Da Isopregnenolona Na Tolerância R
    18 ORIGINAL ARTICLE Effect of isopregnanolone on rapid tolerance to the anxiolytic effect of ethanol Influência da isopregnenolona na tolerância rápida ao efeito ansiolítico do etanol Thaize Debatin,1 Adriana Dias Elpo Barbosa2 Original version accepted in Portuguese Abstract Objective: It has been shown that neurosteroids can either block or stimulate the development of chronic and rapid tolerance to the incoordination and hypothermia caused by ethanol consumption. The aim of the present study was to investigate the influence of isopregnanolone on the development of rapid tolerance to the anxiolytic effect of ethanol in mice. Method: Male Swiss mice were pretreated with isopregnanolone (0.05, 0.10 or 0.20 mg/kg) 30 min before administration of ethanol (1.5 g/kg). Twenty-four hours later, all animals we tested using the plus-maze apparatus. The first experiment defined the doses of ethanol that did or did not induce rapid tolerance to the anxiolytic effect of ethanol. In the second, the influence of pretreatment of mice with isopregnanolone (0.05, 0.10 or 0.20 mg/kg) on rapid tolerance to ethanol (1.5 g/kg) was studied. Conclusions: The results show that pretreatment with isopregnanolone interfered with the development of rapid tolerance to the anxiolytic effect of ethanol. Keywords: Ethanol; Drug tolerance; Anti-anxiety agents; Mice; Alcoholism Resumo Objetivo: Estudos prévios têm mostrado que os neuroesteróides podem bloquear ou estimular o desenvolvimento da tolerância rápida e crônica aos efeitos de incoordenação e hipotermia produzidos pelo etanol. O objetivo do presente estudo foi investigar a influência da isopregnenolona sobre o desenvolvimento da tolerância rápida ao efeito ansiolítico do etanol em camundongos.
    [Show full text]
  • Epipregnanolone and a Novel Synthetic Neuroactive Steroid Reduce Reduce Alcohol Self- Administration in Rats
    University of Texas at El Paso From the SelectedWorks of Laura Elena O'Dell 2005 Epipregnanolone and a novel synthetic neuroactive steroid reduce reduce alcohol self- administration in rats. Laura O'Dell, University of Texas at El Paso Available at: https://works.bepress.com/laura_odell/23/ Pharmacology, Biochemistry and Behavior 81 (2005) 543 – 550 www.elsevier.com/locate/pharmbiochembeh Epipregnanolone and a novel synthetic neuroactive steroid reduce alcohol self-administration in rats L.E. O’Della,b, R.H. Purdya,c,d, D.F. Coveye, H.N. Richardsona, M. Robertoa, G.F. Kooba,* aDepartment of Neuropharmacology, The Scripps Research Institute, CVN-7, 10550 North Torrey Pines Rd., La Jolla, CA, 92037, USA bDepartment of Psychology, The University of Texas at El Paso, El Paso, TX, USA cDepartment of Psychiatry, University of California San Diego, La Jolla, CA, USA dDepartment of Veterans Affairs Medical Center and Veterans Medical Research Foundation, San Diego, CA, USA eDepartment of Molecular Biology and Pharmacology, Washington University School of Medicine, St Louis, MO, USA Received 6 September 2004; received in revised form 14 March 2005; accepted 31 March 2005 Available online 9 June 2005 Abstract This study was designed to compare the effects of several neuroactive steroids with varying patterns of modulation of g-aminobutyric acid (GABA)A and NMDA receptors on operant self-administration of ethanol or water. Once stable responding for 10% (w/v) ethanol was achieved, separate test sessions were conducted in which male Wistar rats were allowed to self-administer ethanol or water following pre-treatment with vehicle or one of the following neuroactive steroids: (3h,5h)-3-hydroxypregnan-20-one (epipregnanolone; 5, 10, 20 mg/kg; n =12), (3a,5h)-20-oxo-pregnane-3-carboxylic acid (PCA; 10, 20, 30 mg/kg; n =10), (3a,5h)-3-hydroxypregnan-20-one hemisuccinate (pregnanolone hemisuccinate; 5, 10, 20 mg/kg; n =12) and (3a,5a)-3-hydroxyandrostan-17-one hemisuccinate (androsterone hemisuccinate; 5, 10, 20 mg/kg; n =11).
    [Show full text]
  • Download Product Insert (PDF)
    PRODUCT INFORMATION Epipregnanolone Item No. 34295 CAS Registry No.: 128-21-2 O Formal Name: (5β)-3β-hydroxy-pregnan-20-one Synonyms: NSC 21450, 5β-Pregnan-3β-ol-20-one MF: C21H34O2 FW: 318.5 H Purity: ≥98% H H Supplied as: A solid Storage: -20°C HO Stability: ≥2 years H Information represents the product specifications. Batch specific analytical results are provided on each certificate of analysis. Laboratory Procedures Epipregnanolone is supplied as a solid. A stock solution may be made by dissolving the epipregnanolone in the solvent of choice, which should be purged with an inert gas. Epipregnanolone is soluble in organic solvents such as ethanol, DMSO, and dimethyl formamide (DMF). The solubility of epipregnanolone in ethanol is approximately 5 mg/ml and approximately 30 mg/ml in DMSO and DMF. Description Epipregnanolone is a neurosteroid and an active metabolite of the steroid hormone pregnenolone (Item No. 19864).1 It is enzymatically formed from prognenolone via the intermediates progesterone (Item No. 15876) and 5β-dihydroprogesterone in the placenta.2 Epipregnanolone inhibits spontaneous 3 contractions in myometrial strips isolated from at-term pregnant women (IC50 = 156 µM). Epipregnanolone (10 and 20 mg/kg) decreases operant alcohol self-administration in rats.4 Maternal plasma levels of epipregnanolone increase over the duration of pregnancy. References 1. Prince, R.J. and Simmonds, M.A. 5β-pregnan-3β-ol-20-one, a specific antagonist at the neurosteroid site of the GABAA receptor-complex. Neurosci. Lett. 135(2), 273-275 (1992). 2. Hill, M., Cibula, D., Havlíkova, H., et al. Circulating levels of pregnanolone isomers during the third trimester of human pregnancy.
    [Show full text]
  • Alteration of the Steroidogenesis in Boys with Autism Spectrum Disorders
    Janšáková et al. Translational Psychiatry (2020) 10:340 https://doi.org/10.1038/s41398-020-01017-8 Translational Psychiatry ARTICLE Open Access Alteration of the steroidogenesis in boys with autism spectrum disorders Katarína Janšáková 1, Martin Hill 2,DianaČelárová1,HanaCelušáková1,GabrielaRepiská1,MarieBičíková2, Ludmila Máčová2 and Daniela Ostatníková1 Abstract The etiology of autism spectrum disorders (ASD) remains unknown, but associations between prenatal hormonal changes and ASD risk were found. The consequences of these changes on the steroidogenesis during a postnatal development are not yet well known. The aim of this study was to analyze the steroid metabolic pathway in prepubertal ASD and neurotypical boys. Plasma samples were collected from 62 prepubertal ASD boys and 24 age and sex-matched controls (CTRL). Eighty-two biomarkers of steroidogenesis were detected using gas-chromatography tandem-mass spectrometry. We observed changes across the whole alternative backdoor pathway of androgens synthesis toward lower level in ASD group. Our data indicate suppressed production of pregnenolone sulfate at augmented activities of CYP17A1 and SULT2A1 and reduced HSD3B2 activity in ASD group which is partly consistent with the results reported in older children, in whom the adrenal zona reticularis significantly influences the steroid levels. Furthermore, we detected the suppressed activity of CYP7B1 enzyme readily metabolizing the precursors of sex hormones on one hand but increased anti-glucocorticoid effect of 7α-hydroxy-DHEA via competition with cortisone for HSD11B1 on the other. The multivariate model found significant correlations between behavioral indices and circulating steroids. From dependent variables, the best correlation was found for the social interaction (28.5%). Observed changes give a space for their utilization as biomarkers while reveal the etiopathogenesis of ASD.
    [Show full text]
  • Calcium-Engaged Mechanisms of Nongenomic Action of Neurosteroids
    Calcium-engaged Mechanisms of Nongenomic Action of Neurosteroids The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters Citation Rebas, Elzbieta, Tomasz Radzik, Tomasz Boczek, and Ludmila Zylinska. 2017. “Calcium-engaged Mechanisms of Nongenomic Action of Neurosteroids.” Current Neuropharmacology 15 (8): 1174-1191. doi:10.2174/1570159X15666170329091935. http:// dx.doi.org/10.2174/1570159X15666170329091935. Published Version doi:10.2174/1570159X15666170329091935 Citable link http://nrs.harvard.edu/urn-3:HUL.InstRepos:37160234 Terms of Use This article was downloaded from Harvard University’s DASH repository, and is made available under the terms and conditions applicable to Other Posted Material, as set forth at http:// nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of- use#LAA 1174 Send Orders for Reprints to [email protected] Current Neuropharmacology, 2017, 15, 1174-1191 REVIEW ARTICLE ISSN: 1570-159X eISSN: 1875-6190 Impact Factor: 3.365 Calcium-engaged Mechanisms of Nongenomic Action of Neurosteroids BENTHAM SCIENCE Elzbieta Rebas1, Tomasz Radzik1, Tomasz Boczek1,2 and Ludmila Zylinska1,* 1Department of Molecular Neurochemistry, Faculty of Health Sciences, Medical University of Lodz, Poland; 2Boston Children’s Hospital and Harvard Medical School, Boston, USA Abstract: Background: Neurosteroids form the unique group because of their dual mechanism of action. Classically, they bind to specific intracellular and/or nuclear receptors, and next modify genes transcription. Another mode of action is linked with the rapid effects induced at the plasma membrane level within seconds or milliseconds. The key molecules in neurotransmission are calcium ions, thereby we focus on the recent advances in understanding of complex signaling crosstalk between action of neurosteroids and calcium-engaged events.
    [Show full text]
  • Comparison of Strategies for the Determination of Sterol Sulfates Via GC-MS Leading to a Novel Deconjugation-Derivatization Protocol
    molecules Article Comparison of Strategies for the Determination of Sterol Sulfates via GC-MS Leading to a Novel Deconjugation-Derivatization Protocol Julia Junker 1 , Isabelle Chong 1, Frits Kamp 2, Harald Steiner 2,3, Martin Giera 4 , Christoph Müller 1 and Franz Bracher 1,* 1 Department of Pharmacy-Center for Drug Research, Ludwig-Maximilians University Munich, Butenandtstraße 5-13, 81377 Munich, Germany 2 Biomedical Center (BMC), Metabolic Biochemistry, Ludwig-Maximilians University Munich, Feodor-Lynen-Strasse 17, 81377 Munich, Germany 3 German Center for Neurodegenerative Diseases (DZNE), Feodor-Lynen-Strasse 17, 81377 Munich, Germany 4 Leiden University Medical Center, Center for Proteomics and Metabolomics, Albinusdreef 2, 2300 RC Leiden, The Netherlands * Correspondence: [email protected]; Tel.: +49-892-1807-7301 Academic Editor: Yasunori Yaoita Received: 27 April 2019; Accepted: 21 June 2019; Published: 26 June 2019 Abstract: Sulfoconjugates of sterols play important roles as neurosteroids, neurotransmitters, and ion channel ligands in health and disease. In most cases, sterol conjugate analysis is performed with liquid chromatography-mass spectrometry. This is a valuable tool for routine analytics with the advantage of direct sterol sulfates analysis without previous cleavage and/or derivatization. The complementary technique gas chromatography-mass spectrometry (GC-MS) is a preeminent discovery tool in the field of sterolomics, but the analysis of sterol sulfates is hampered by mandatory deconjugation and derivatization. Despite the difficulties in sample workup, GC-MS is an indispensable tool for untargeted analysis and steroid profiling. There are no general sample preparation protocols for sterol sulfate analysis using GC-MS. In this study we present a reinvestigation and evaluation of different deconjugation and derivatization procedures with a set of representative sterol sulfates.
    [Show full text]
  • Novel Targets for Neuroactive Steroid Synthesis and Action and Their Relevance for Translational Research P
    Journal of Neuroendocrinology, 2016, 28, 10.1111/jne.12351 REVIEW ARTICLE © 2015 British Society for Neuroendocrinology Neurosteroidogenesis Today: Novel Targets for Neuroactive Steroid Synthesis and Action and Their Relevance for Translational Research P. Porcu*, A. M. Barron†, C. A. Frye‡§, A. A. Walf‡§¶, S.-Y. Yang**, X.-Y. He**, A. L. Morrow††, G. C. Panzica‡‡ and R. C. Melcangi§§ *Neuroscience Institute, National Research Council of Italy (CNR), Cagliari, Italy. †Molecular Imaging Center, National Institute of Radiological Sciences, Anagawa, Inage-ku, Chiba, Japan. ‡IDEA Network of Biomedical Research Excellence and Department of Chemistry and Biochemistry, University of Alaska–Fairbanks, Fairbanks, AK, USA. §Department of Psychology, The University at Albany, Albany, NY, USA. ¶Department of Cognitive Science, Rensselaer Polytechnic Institute, Troy, NY, USA. **Department of Developmental Biochemistry, NYS Institute for Basic Research in Developmental Disabilities, Staten Island, NY, USA. ††Departments of Psychiatry and Pharmacology, Bowles Center for Alcohol Studies, University of North Carolina School of Medicine, Chapel Hill, NC, USA. ‡‡Department of Neuroscience, University of Turin, and NICO – Neuroscience Institute Cavalieri Ottolenghi, Orbassano, Italy. §§Dipartimento di Scienze Farmacologiche e Biomolecolari, Universita degli Studi di Milano, Milan, Italy. Journal of Neuroactive steroids are endogenous neuromodulators synthesised in the brain that rapidly alter Neuroendocrinology neuronal excitability by binding to membrane
    [Show full text]
  • Reduced Progesterone Metabolites in Human Late Pregnancy
    Physiol. Res. 60: 225-241, 2011 https://doi.org/10.33549/physiolres.932077 REVIEW Reduced Progesterone Metabolites in Human Late Pregnancy M. HILL1,2, A. PAŘÍZEK2, R. KANCHEVA1, J. E. JIRÁSEK3 1,2Institute of Endocrinology, Prague, Czech Republic, 2Department of Obstetrics and Gynecology of the First Faculty of Medicine and General Teaching Hospital, Prague, Czech Republic, 3Department of Clinical Biochemistry and Laboratory Diagnostics of the First Faculty of Medicine and General Teaching Hospital, Prague, Czech Republic Received November 20, 2010 Accepted November 25, 2010 On-line November 29, 2010 Summary Corresponding author In this review, we focused on the intersection between steroid A. Pařízek, Department of Obstetrics and Gynecology of the metabolomics, obstetrics and steroid neurophysiology to give a First Faculty of Medicine and General Teaching Hospital, comprehensive insight into the role of sex hormones and Apolinářská 18, 128 51 Prague 2, Czech Republic. E-mail: neuroactive steroids (NAS) in the mechanism controlling [email protected] pregnancy sustaining. The data in the literature including our studies show that there is a complex mechanism providing synthesis of either pregnancy sustaining or parturition provoking Introduction steroids. This mechanism includes the boosting placental synthesis of CRH with approaching parturition inducing the Although the effects of neuroactive and excessive synthesis of 3β-hydroxy-5-ene steroid sulfates serving neuroprotective 5α/β-reduced progesterone metabolites primarily as precursors for placental synthesis of progestogens, were extensively studied, the physiological relevance of estrogens and NAS. The distribution and changing activities of these substances remains frequently uncertain due to the placental oxidoreductases are responsible for the activation or lack of metabolomic data.
    [Show full text]
  • Chronic Cigarette Smoking Alters Circulating Sex Hormones and Neuroactive Steroids in Premenopausal Women
    Physiol. Res. 61: 97-111, 2012 https://doi.org/10.33549/physiolres.932164 Chronic Cigarette Smoking Alters Circulating Sex Hormones and Neuroactive Steroids in Premenopausal Women M. DUŠKOVÁ1, K. ŠIMŮNKOVÁ1, M. HILL1,4, M. VELÍKOVÁ1, J. KUBÁTOVÁ1, L. KANCHEVA1, H. KAZIHNITKOVÁ1, H. HRUŠKOVIČOVÁ1, H. POSPÍŠILOVÁ1, B. RÁCZ1, M. SALÁTOVÁ1, V. CIRMANOVÁ1, E. KRÁLÍKOVÁ2,3, L. STÁRKA1, A. PAŘÍZEK4 1Institute of Endocrinology, Prague, Czech Republic, 2Institute of Hygiene and Epidemiology, First Faculty of Medicine, Charles University, Prague, Czech Republic, 3Tobacco Dependence Treatment Centre, Third Medical Department – Department of Metabolism and Endocrinology, First Faculty of Medicine, Charles University, Prague, Czech Republic, 4Department of Obstetrics and Gynecology of the First Faculty of Medicine, Charles University, Prague, Czech Republic Received February 18, 2011 Accepted October 27, 2011 On-line December 20, 2011 Summary lutropin/follitropin ratio. In conclusion, chronic cigarette smoking Chronic smoking alters the circulating levels of sex hormones and augments serum androgens and their 5α/β-reduced metabolites possibly also the neuroactive steroids. However, the data (including GABAergic substances) but suppresses the levels of available is limited. Therefore, a broad spectrum of free and estradiol in the LP and SHBG and may induce hyperandrogenism conjugated steroids and related substances was quantified by in female smokers. The female smokers had pronouncedly GC-MS and RIA in premenopausal smokers and in age-matched increased serum progestogens but paradoxically suppressed (38.9±7.3 years of age) non-smokers in the follicular (FP) and levels of their GABA-ergic metabolites. Further investigation is luteal phases (LP) of menstrual cycle (10 non-smokers and needed concerning these effects.
    [Show full text]
  • The Sigma1 Protein As a Target for the Non-Genomic Effects of Neuro(Active)Steroids: Molecular, Physiological, and Behavioral Aspects François P
    J Pharmacol Sci 100, 93 – 118 (2006) Journal of Pharmacological Sciences ©2006 The Japanese Pharmacological Society Critical Review The Sigma1 Protein as a Target for the Non-genomic Effects of Neuro(active)steroids: Molecular, Physiological, and Behavioral Aspects François P. Monnet1 and Tangui Maurice2,* 1Unité 705 de l’Institut National de la Santé et de la Recherche Médicale, Unité Mixte de Recherche 7157 du Centre National de la Recherche Scientifique, Université de Paris V et VII, Hôpital Lariboisière-Fernand Widal, 2, rue Ambroise Paré, 75475 Paris cedex 10, France 2Unité 710 de l’Institut National de la Santé et de la Recherche Médicale, Ecole Pratique des Hautes Etudes, Université de Montpellier II, cc 105, place Eugène Bataillon, 34095 Montpellier cedex 5, France Received December 15, 2005 Abstract. Steroids synthesized in the periphery or de novo in the brain, so called ‘neuro- steroids’, exert both genomic and nongenomic actions on neurotransmission systems. Through rapid modulatory effects on neurotransmitter receptors, they influence inhibitory and excitatory neurotransmission. In particular, progesterone derivatives like 3α-hydroxy-5α-pregnan-20-one (allopregnanolone) are positive allosteric modulators of the γ-aminobutyric acid type A (GABAA) receptor and therefore act as inhibitory steroids, while pregnenolone sulphate (PREGS) and dehydroepiandrosterone sulphate (DHEAS) are negative modulators of the GABAA receptor and positive modulators of the N-methyl-D-aspartate (NMDA) receptor, therefore acting as excitatory neurosteroids. Some steroids also interact with atypical proteins, the sigma (σ) receptors. Recent studies particularly demonstrated that the σ1 receptor contributes effectively to their pharmaco- logical actions. The present article will review the data demonstrating that the σ1 receptor binds neurosteroids in physiological conditions.
    [Show full text]
  • Multidisciplinary Analysis of Biological Effects of Novel Analogs of The
    UNIVERSITÉ DE STRASBOURG ÉCOLE DOCTORALE des Sciences de la vie et de la santé (ED 414) INSERM UMR_S U1119 Biopathologies de la Myéline, Neuroprotection et Stratégies Thérapeutiques THÈSE En cotutelle avec l´Albert-Ludwigs-Universität Freiburg, Allemagne présentée par : Mona KAROUT soutenue le : 30 Septembre 2015 pour obtenir le grade de : Docteur de l’université de Strasbourg Discipline / Spécialité : Neurosciences Multidisciplinary analysis of biological effects of novel analogs of the neurosteroid allopregnanolone: evidence for a proliferative, neurogenic and ne uroprote ctive action THÈSE dirigée par : M. MENSAH-NYAGAN Ayikoé, Guy Professeur, Université de Strasbourg, France M. HOFMANN Hans-Dieter Professeur, Albert-Ludwigs-Universität Freiburg, Allemagne RAPPORTEURS : M. FISCHBACH Karl-Friedrich Professeur, Albert-Ludwigs-Universität Freiburg, Allemagne M. SCHWEMMLE Martin Professeur, Albert-Ludwigs-Universität Freiburg, Allemagne AUTRES MEMBRES DU JURY : M. DUFOUR André Professeur, Université de Strasbourg, France Mme. PATTE-MENSAH Christine Docteur, Université de Strasbourg, France !"# $%&'(%# To my parents A mes parents Acknowledgement ACKNOWLEDGEMENT First of all, I would like to express my appreciation and gratitude to all members of my thesis committee, Prof. Karl-Friedrich Fischbach, Prof. Martin Schwemmle, Prof. André Dufour and Dr. Christine Patte-Mensah for taking the time to evaluate my thesis. Furthermore, I would like to express my deepest gratitude to my two PhD supervisors Prof. Ayikoé Guy Mensah-Nyagan and Prof. Hans-Dieter Hofmann. I am very thankful to you Prof. Mensah-Nyagan for giving me a great opportunity for performing this joint French-German PhD. Thank you very much for the continuous support, for your patience, enthusiasm, passion for research and immense knowledge.
    [Show full text]
  • Research Article
    Available Online at http://www.recentscientific.com International Journal of CODEN: IJRSFP (USA) Recent Scientific International Journal of Recent Scientific Research Research Vol. 9, Issue, 6(E), pp. 27560-27565, June, 2018 ISSN: 0976-3031 DOI: 10.24327/IJRSR Research Article BIOSYNTHESIS OF NEUROSTEROID AND PHARMACOLOGYCAL ACTION Vandna Dewangan*., Trilochan Satapthy and Ram Sahu Department of Pharmacology, Columbia Institute of Pharmacy, Tekari, Near Vidhansabha, Raipur-493111(C.G.) India DOI: http://dx.doi.org/10.24327/ijrsr.2018.0906.2285 ARTICLE INFO ABSTRACT Article History: Over the past decade, it has become clear that the brain, like the gonad, adrenal and placenta, is a steroid genic organ. Neurosteroids are synthetized in the central and the peripheral nervous system, Received 20th March, 2018 in glial cells, and also in neurons, from cholesterol or steroidal precursors imported from peripheral Received in revised form 27th sources. However, unlike classic steroid genic tissues, the synthesis of steroids in the nervous April, 2018 system requires the coordinate expression and regulation of the genes encoding the steroid genic Accepted 5th May, 2018 enzymes in several different cell types (neurons and glia) at different locations in the nervous Published online 28th June, 2018 system, and at distances from the cell bodies. The steroids synthesized by the brain and nervous system, given the name neurosteroids Progesterone itself is also a neurosteroid, and a progesterone Key Words: receptor has been detected in peripheral and central glial cells. At different sites in the brain, Neurosteroid, Steroid hormones, neurosteroid concentrations vary according to environmental and behavioural circumstances, such as Progesterone, Glial Cell, Nuclear receptor, stress, sex recognition, or aggressiveness.
    [Show full text]